ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,741, issued on Oct. 14, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates" was invented by Austin G. Smith (Cary, N.C.), Jason S. Tedrow (Salem, Mass.), Gabrielle St-Pierre (Thousand Oaks, Calif.), Oliver Ralf Thiel (Lexington, Mass.), Liang Huang (Thousand Oaks, Calif.), Philipp C. Roosen (Thousand Oaks, Calif.), John T. Colyer (Newbury Park, Calif.), Kyle D. Baucom (Ventura, Calif.), Ari Ericson (Thousand Oaks, Calif.), Matthew G. Beaver (Natick, Mass.), Rahul P. Sangodkar (Boston), Michael A. Lovette (Camarillo, Calif.), Robert Ronald Milburn (Belmont, Calif.), Alan H. Cherney (Somerville, Mass.) and Sheng C...